Bacterial Polyamines Produced in the Gut Extend Lifespan in Experimental Flies
Researchers created gnotobiotic flies colonized with engineered Escherichia coli either capable of or deficient in polyamine biosynthesis to isolate the effects of these bacterial metabolites on host lifespan independent of other microbiome factors. Polyamines derived exclusively from gut bacteria significantly prolonged fly lifespan and suppressed immune response markers, suggesting these bacterial metabolites play a direct role in longevity regulation. The findings build on previous research indicating that polyamines represent an important mechanistic link between microbiome composition and aging in animal models.
Gut bacteria produce numerous compounds that support cellular health, many of which decline as people and animals age and their microbial communities shift unfavorably. Scientists have long known that transplanting microbiota from younger organisms to older ones delivers measurable health improvements, yet identifying which specific bacterial substances drive these benefits has remained challenging. This study addressed that gap by using flies hosting only engineered bacteria—either capable of manufacturing polyamines or genetically stripped of that ability—while keeping diet constant to isolate polyamine effects from other variables.
The research focused on polyamines like putrescine and spermidine, key bacterial metabolites previously linked to extended lifespan in mice when colon levels increased. Flies receiving polyamine-producing bacteria lived significantly longer than those with non-producing strains. The engineered bacteria also dampened immune markers associated with aging stress, suggesting polyamines may slow deterioration through multiple biological pathways rather than a single mechanism.
These findings could reshape how researchers approach aging interventions, potentially shifting focus from broad microbiome replacement toward targeted metabolite supplementation. If polyamine pathways prove similarly important in humans, future therapies might involve bacterial strains engineered to boost these compounds or direct polyamine supplements. However, translating fruit fly results to people requires extensive additional research, and the practical application timeline remains uncertain. The work may most immediately influence basic aging science and personalized probiotic development.